Key result
Standardized cerebrovascular reactivity testing using BOLD MRI and precise targeting of arterial carbon dioxide provides reproducible assessments of brain vascular health and collateral flow.
Why the study?
The authors sought to review their insights from two decades of work developing a standardized stimulus-response approach to interrogate, measure, classify, and interpret cerebral vascular physiology in health and disease.
This perspective reviews the physiological basis and methodological optimization of cerebrovascular reactivity testing using MRI BOLD to assess stroke risk and collateral flow.
Supports reproducible BOLD MRI cerebrovascular reactivity assessment; leaves open its clinical integration pending prospective outcome trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fisher et al. (2021) conducted a review in Cerebrovascular disease. Cerebrovascular reactivity testing was evaluated. Standardized cerebrovascular reactivity testing using BOLD MRI and precise targeting of arterial carbon dioxide provides reproducible assessments of brain vascular health and collateral flow.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: